Previously known as the IHCAN Conferences Webinars
Webinars
Our series of hour-long webinars are completely free to attend. Covering a broad range of subjects, simply use the registration links below to register.
Once registered, you will receive three reminder emails – one a week before the webinar, one a day before and one on the day of the webinar. Each webinar is recorded – you will be sent a link to the recording approximately 48 hours after the event.
*Please note, you are only eligible for the CPD hours if you attend the webinar live*
We apply for CPD accreditation for every webinar from:
Tuesday 24 November 2026
18.30 – 19.30
‘Mould & the Cell: Building Resilience from the Inside Out’
Mould exposure is often approached through avoidance and detoxification, but understanding the cellular response to environmental stressors adds an important layer to the clinical picture. In this webinar, Dr. John Kim, Pharm.D., FAARFM, will explore mould through a cellular health lens, connecting environmental exposures with mitochondrial function, cell membrane health, redox balance, nervous system regulation, gut health, and endogenous detoxification pathways. He will discuss strategies designed to support normal cellular function and resilience, with an emphasis on building physiological capacity and supporting the cellular foundations that help the body adapt, regulate, and restore balance.
About Kayla Butera
Kayla Butera is the International Sales Manager and Educator at BodyBio, a third-generation supplement company serving over 35,000 healthcare practitioners worldwide with a core focus on cellular membrane health. She is passionate about educating healthcare enthusiasts on the science and clinical applications of BodyBio’s foundational supplements, supporting global partners through clear, science-based, and collaborative partnerships.
Kayla studied biology and nutrition with pre-medical training at Tufts University (Boston, USA), where she gained valuable experience at the Cleveland Clinic’s Department of Integrative Medicine and conducted cellular senescence research at the Jean Mayer USDA Human Nutrition Research Center on Aging. She continues to advance her expertise by studying Clinical Psychoneuroimmunology at the Pruimboom Institute and mitochondrial medicine under cellular health expert Justine Stenger, bringing a thoughtful, systems-oriented, and integrative perspective to her work.
In addition to her scientific training, Kayla is a Art Wellness Teacher and Dragon’s Way Qigong Practitioner, having studied under Grand Master Nan Lu (New York, New York). This training informs her appreciation for the integration of cellular physiology, bioenergetics, and traditional energetic frameworks, further enriching her holistic approach to health.
Sponsored by
Tuesday 1 December 2026
18.30 – 19.30
‘Keep the Muscle. Lose the Weight. A Proven GLP-1 Supplement’
Body composition leads patient conversations for long term weight health. Explore the science and discovery of Amarasate, the ground-breaking 4th human clinical showing weight loss, fat loss and muscle maintenance.
About Dr Edward Walker, PhD. Senior Scientist. New Zealand Bioeconomy Science Institute.
He completed his PhD at the University of Auckland on the antioxidant eects of berry fruits, and has continued to research how dietary plant compounds can improve health and wellness.
He works at The New Zealand Institute for Plant and Food Research, undertaking commercially focused research of nutraceutical products for human health applications, with a focus on clinical validation of lab-based results. He is also a guest lecturer at the University of Auckland on the topic of nutraceuticals and functional foods.
Sponsored by
Tuesday 8 December 2026
18.30 – 19.30
‘The Silent Decades: Acting Early to Preserve Cognitive Function’
Alzheimer’s disease usually becomes obvious after the age of 65, but its biology starts 15 to 25 years earlier, in midlife. In those years the immune system allows us a clear window of vision.
Antibodies to brain proteins, growth factors and blood-brain barrier structures, and to the pathogens, chemicals and foods that cross-react with amyloid-β, can signal clear and developing risk long before cognitive tests change.
This important session takes practitioners from the epidemiology of cognitive decline to the science behind functional testing for this population with Cyrex Alzheimer’s Linz panel.
It explains what each target protein does, what an antibody against it may indicate, and why barrier integrity decides whether circulating antibodies become harmful.
We will review the evidence that autoantibodies and other biomarkers appear years before symptoms, and position this alongside the Lancet Commission finding that 45% of dementia is potentially modifiable.
We will also include how to use test results to guide practical intervention strategy with care.
We will be overing two groups: those with symptoms or a diagnosis, where the goal is improved function, and high-risk patients with a strong family history and positive findings but no measurable decline, where the goal is to reverse the inflammatory process and lower the risk of disease developing.
Learning outcomes
By the end of this session, participants will be able to:
- Describe the prevalence of cognitive decline, mild cognitive impairment and Alzheimer’s disease, and other conditions linked to the antigens on Alzheimer’s LINX™
- Explain the function of the proteins targeted by the panel and what an IgG response against each may indicate
- Interpret results in the context of blood-brain barrier integrity, molecular mimicry and environmental triggers
- Summarise the evidence that immune and biomarker changes come before symptoms by a decade or more
- Apply a results-guided intervention strategy for both symptomatic and high-risk patients
Sponsored by
Tuesday 2 February 2027
18.30 – 19.30
‘Rethinking Mould Illness: Cellular & Mitochondrial Drivers
of Mould Illness’
What if mould exposure is not simply about the presence of toxins, but about the body’s cellular capacity to respond and recover?
In this presentation, Dr. John Kim explores the cellular and mitochondrial mechanisms implicated in mould-related illness, moving beyond conventional detoxification frameworks to examine mitochondrial bioenergetics, membrane integrity and immune signalling. He will discuss how environmental stressors may influence cellular energy production, redox balance and inflammatory pathways, and how these interconnected systems contribute to physiological resilience.
Bridging cellular science with clinical application, Dr. Kim will explore how targeted lipid and essential nutrient support may help maintain membrane architecture, mitochondrial function and metabolic adaptability. Through a systems-based approach, practitioners will gain practical insights into integrating these nutritional strategies into individualised care plans, supporting patients throughout their journey towards cellular resilience and recovery.
About Dr. John Kim, PharmD, FAARFM
Dr. John Kim, PharmD, FAARFM, is a functional medicine practitioner, pharmacist, clinical educator and international speaker specialising in cellular bioenergetics, mitochondrial health, environmental stressors and mould toxicity. A graduate of Rutgers University’s Ernest Mario School of Pharmacy, he holds advanced fellowship training in functional medicine through the American Academy of Anti-Aging Medicine (A4M). He is the founder of Kim Wellness and the ENCORE Method™ and serves as a Clinical Science Liaison for BodyBio. Dr. Kim takes a systems-based, cellular approach to health, exploring the interconnected roles of cellular membrane integrity, mitochondrial function, nervous system regulation, microbiome health and environmental exposures. His educational work focuses on the Cellular Danger Response (CDR), mitochondrial dysfunction and the physiological mechanisms underlying environmental stress, helping practitioners move beyond symptom-focused approaches towards a deeper understanding of cellular resilience and recovery.
Sponsored by
Tuesday 9 February 2026
18.30 – 19.30
‘Beyond Hormone Levels: Connecting Genetics, Metabolism and Clinical Symptoms’
Integrating Endocrine Nutrigenomics and DUTCH Testing for Personalised Hormone Health
Learning outcomes:
• Explain the relationship between genetic variation, environmental influences and the expression of endocrine function.
• Identify key endocrine and hormone-metabolism pathways assessed through nutrigenomic and DUTCH testing.
• Integrate genetic and functional hormone results within a Functional Medicine framework.
• Critically interpret concordant and discordant results without overattributing symptoms to individual SNPs.
• Develop personalised nutrition and lifestyle strategies informed by the patient’s clinical presentation and relevant laboratory findings.
About Sue Camp MSC FMCP mBANT, rCNHC
Sue Camp is an experienced Registered Nutritional Therapist and IFM Certified Practitioner with an MSc in Personalised Nutrition and advanced training in Clinical Psychoneuroimmunology (cPNI).
She brings together nutritional science, functional medicine and psychoneuroimmunology to explore the complex interactions between metabolism, the immune system, the nervous system and overall health.
Alongside her private practice, NutriPsyence, Sue is an experienced clinical educator and international speaker, regularly presenting at professional conferences, seminars and practitioner training events in the UK and internationally.
Her particular passion lies in translating complex scientific mechanisms into practical, personalised strategies that support resilience, metabolic health and long-term wellbeing.
Sponsored by
The IHCAN Summit Webinars are provided for professional education and debate and is not intended to be used by non-medically qualified individuals as a substitute for, or basis of, medical treatment. We take your privacy seriously, by registering for any of our webinars you accept our privacy policy.